Tumor Virus RNA Biology Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA.
Int J Mol Sci. 2022 Apr 29;23(9):4943. doi: 10.3390/ijms23094943.
Human papillomaviruses (HPV) are a group of small non-enveloped DNA viruses whose infection causes benign tumors or cancers. HPV16 and HPV18, the two most common high-risk HPVs, are responsible for ~70% of all HPV-related cervical cancers and head and neck cancers. The expression of the HPV genome is highly dependent on cell differentiation and is strictly regulated at the transcriptional and post-transcriptional levels. Both HPV early and late transcripts differentially expressed in the infected cells are intron-containing bicistronic or polycistronic RNAs bearing more than one open reading frame (ORF), because of usage of alternative viral promoters and two alternative viral RNA polyadenylation signals. Papillomaviruses proficiently engage alternative RNA splicing to express individual ORFs from the bicistronic or polycistronic RNA transcripts. In this review, we discuss the genome structures and the updated transcription maps of HPV16 and HPV18, and the latest research advances in understanding RNA cis-elements, intron branch point sequences, and RNA-binding proteins in the regulation of viral RNA processing. Moreover, we briefly discuss the epigenetic modifications, including DNA methylation and possible APOBEC-mediated genome editing in HPV infections and carcinogenesis.
人乳头瘤病毒(HPV)是一组小型无包膜 DNA 病毒,其感染可导致良性肿瘤或癌症。HPV16 和 HPV18 是两种最常见的高危 HPV,它们导致了约 70%的所有 HPV 相关宫颈癌和头颈部癌症。HPV 基因组的表达高度依赖于细胞分化,并在转录和转录后水平受到严格调控。感染细胞中差异表达的 HPV 早期和晚期转录本是含有不止一个开放阅读框(ORF)的内含子双顺反子或多顺反子 RNA,这是因为使用了替代的病毒启动子和两个替代的病毒 RNA 多聚腺苷酸化信号。乳头瘤病毒能够有效地进行选择性 RNA 剪接,从双顺反子或多顺反子 RNA 转录本中表达单个 ORF。在这篇综述中,我们讨论了 HPV16 和 HPV18 的基因组结构和最新的转录图谱,以及在理解病毒 RNA 加工调控中的 RNA 顺式元件、内含子分支点序列和 RNA 结合蛋白方面的最新研究进展。此外,我们还简要讨论了 HPV 感染和致癌过程中的表观遗传修饰,包括 DNA 甲基化和可能的 APOBEC 介导的基因组编辑。
Int J Mol Sci. 2022-4-29
Front Biosci. 2006-9-1
World J Urol. 2025-8-20
Indian J Sex Transm Dis AIDS. 2025
J Transl Med. 2025-4-29
Front Immunol. 2025-4-8
Hum Vaccin Immunother. 2025-12
Nat Rev Microbiol. 2022-2
Mol Cell Biochem. 2021-12
JCI Insight. 2021-8-23